{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T03:58:49Z","timestamp":1787371129472,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.oret.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:26:24Z","timestamp":1746818784000},"page":"1090-1097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of Adverse Systemic Events in Retinal Vein Occlusion"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4549-5763","authenticated-orcid":false,"given":"Emily A.","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Markle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Maatouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","article-title":"Natural history of branch retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.005_bib2","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J Glob Health"},{"key":"10.1016\/j.oret.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.005_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1573399811666150615151324","article-title":"Anti-VEGF therapy for retinal vein occlusions","volume":"17","author":"Campa","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.oret.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5318\/wjo.v4.i4.92","article-title":"Pathogenesis, prevention, diagnosis and management of retinal vein occlusion","volume":"4","author":"Keren","year":"2014","journal-title":"World J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.oret.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/OPTH.S128341","article-title":"Systemic abnormalities associated with retinal vein occlusion in young patients","volume":"11","author":"Sinawat","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41433-021-01620-z","article-title":"Long-term outcomes of anti-VEGF treatment of retinal vein occlusion","volume":"36","author":"Spooner","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/OPTH.S125486","article-title":"Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion","volume":"11","author":"Abri Aghdam","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajo.2023.08.022","article-title":"Risk of stroke, myocardial infarction, deep vein thrombosis, pulmonary embolism, and death after retinal vein occlusion","volume":"257","author":"Wai","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib12","article-title":"Retinal vein occlusion and the risk of acute myocardial infarction development: a 12-year nationwide cohort study","volume":"6","author":"Rim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archophthalmol.2011.2","article-title":"Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion","volume":"129","author":"Werther","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/bjophthalmol-2022-321225","article-title":"Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study","volume":"107","author":"Frederiksen","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/IAE.0b013e31806196bc","article-title":"Relationship between retinal vein occlusion and carotid artery lesions","volume":"27","author":"Matsushima","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91401-1","article-title":"Clinical significance of subclinical atherosclerosis in retinal vein occlusion","volume":"11","author":"Lyu","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ophtha.2007.01.031","article-title":"Mortality in patients with branch retinal vein occlusion","volume":"114","author":"Christoffersen","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bjo.2008.151605","article-title":"Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study","volume":"93","author":"Hu","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12916-019-1351-4","article-title":"Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study","volume":"17","author":"Banks","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.oret.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.mayocp.2020.06.057","article-title":"Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants","volume":"96","author":"Pastori","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.oret.2025.05.005_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.chest.2022.05.038","article-title":"Anticoagulation for VTE: impact on the risk of major adverse cardiovascular events","volume":"162","author":"Noumegni","year":"2022","journal-title":"Chest"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302500212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302500212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T02:45:36Z","timestamp":1763779536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302500212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S246865302500212X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.05.005","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Adverse Systemic Events in Retinal Vein Occlusion","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}